Polatuzumab vedotin (solution)

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Polatuzumab vedotin solution is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. The antibody portion is Polatuzumab (HY-P99042), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Polatuzumab vedotin solution has the potential for the research of Large B-cell lymphomas (LBCL).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.40%
  • No. CAS: 1313206-42-6
  • Peso molecular:150000 (average)
  • Almacenamiento:
    Shipping with dry ice

    -80°C, protect from light

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00